Company Filing History:
6 out of 378 
4 out of 12,164 
1 out of 1,210 
Years Active: 2018-2023
Title: Franziska Siegel: A Pioneer in Pharmaceutical Innovations
Introduction
Franziska Siegel is an accomplished inventor based in Berlin, Germany, with a remarkable portfolio of six patents. Her innovative work in the field of pharmaceuticals has contributed significantly to advancements in medical treatments.
Latest Patents
Among her notable recent patents, Siegel has developed PTEFB inhibiting macrocyclic compounds. This invention involves novel modified macrocyclic compounds that exhibit improved tolerability, useful for the treatment and prophylaxis of various disorders, particularly hyper-proliferative disorders, virally induced infectious diseases, and cardiovascular diseases. The invention also includes intermediate compounds that facilitate the preparation of these macrocyclic compounds.
Another significant contribution by Siegel includes the development of 4H-pyrrolo[3,2-c]pyridin-4-one derivatives. These compounds have applications in pharmaceuticals, showcasing her commitment to advancing medical science through her research and innovations.
Career Highlights
Franziska Siegel has had an impressive career, having worked with prominent companies in the pharmaceutical industry, notably Bayer Pharma and Bayer AG. Her contributions to these companies have played a crucial role in the development of pharmaceutical innovations that benefit healthcare.
Collaborations
Throughout her career, Siegel has collaborated with distinguished colleagues, including Philip Lienau and Ulrich Lücking. These partnerships have allowed for a rich exchange of ideas and innovations, further enhancing her work and contributing to successful outcomes in her research and development projects.
Conclusion
Franziska Siegel exemplifies the spirit of innovation and dedication in the pharmaceutical field. Her patents reflect her talent for creating new and effective treatment options, making significant strides in improving patient care. As she continues her work, the impact of her inventions is likely to resonate within the medical community for years to come.